Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 823

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 823
---
 or on
behalf of WuXi Biologics with respect to Licensed ADCs and Licensed Products, including all final protocols and all final reports of each IND-Enabling Study conducted pursuant to an SOW.

(d) Storage of Materials. [***]. WuXi Biologics will deliver such biological materials to Aadi promptly following Aadi’s
written request therefor. Until such time as Aadi requests, WuXi Biologics shall properly store such materials, consistent with the manner in which the materials were stored by or on behalf of WuXi Biologics prior to the Effective Date.

(e) Cooperation. The Parties will cooperate and reasonably agree upon formats and procedures to facilitate the orderly and
efficient exchange of the Licensed Know-How in accordance with this Section 2.3. Without limiting the foregoing, all Licensed Know-How shall be made available to
Aadi (i) in sufficient form and detail to permit Aadi to use and/or practice such technology, to the extent that WuXi Biologics or its Affiliate has such Know-How (or can reasonably generate such Know-How) in such form and detail and (ii) in the language in which it was created together with a complete, certified English translation of the same. Upon the request of Aadi, WuXi Biologics shall, and if
applicable, shall cause its Affiliates to, reasonably cooperate with and assist Aadi as may be necessary or desirable in order to allow Aadi to understand the Licensed Know-How and to utilize the Licensed Know-How for the purposes contemplated in this Agreement. Additionally, upon Aadi’s reasonable request, WuXi Biologics shall provide reasonable technical assistance, including, upon Aadi’s reasonable prior
notice, making appropriate employees of WuXi Biologics, or its relevant Affiliate, available to Aadi at reasonable times, places, and frequency, in each case as mutually agreed by the Parties, for the purpose of assisting Aadi to understand and use
the Licensed Know-How in connection with Aadi’s Development of the Licensed ADCs or Licensed Products.

G-11

(f) Without limiting Sections 2.3(a)-(e) above, Aadi has agreed that, during the Term,
WuXi Biologics shall have the right to designate a Third Party approved by Aadi to transfer the Licensed Know-How (or any part thereof) to Aadi in accordance with this Section 2.3. Such transfer of
Licensed Know-How shall be subject to